Clinical trial
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
NCT00003645
Study timeline
Study start (actual)1999-06-14Date precision: day
Registry last updated2020-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
FlutamideDRUG · verified · RxNorm: flutamide
Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Eastern Cooperative Oncology Groupcollaborator
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003645 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.